全文获取类型
收费全文 | 1931篇 |
免费 | 135篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 48篇 |
妇产科学 | 31篇 |
基础医学 | 232篇 |
口腔科学 | 27篇 |
临床医学 | 276篇 |
内科学 | 364篇 |
皮肤病学 | 43篇 |
神经病学 | 219篇 |
特种医学 | 119篇 |
外科学 | 176篇 |
综合类 | 47篇 |
一般理论 | 3篇 |
预防医学 | 189篇 |
眼科学 | 19篇 |
药学 | 131篇 |
中国医学 | 5篇 |
肿瘤学 | 137篇 |
出版年
2023年 | 11篇 |
2022年 | 40篇 |
2021年 | 79篇 |
2020年 | 44篇 |
2019年 | 69篇 |
2018年 | 64篇 |
2017年 | 43篇 |
2016年 | 43篇 |
2015年 | 56篇 |
2014年 | 57篇 |
2013年 | 100篇 |
2012年 | 84篇 |
2011年 | 106篇 |
2010年 | 37篇 |
2009年 | 57篇 |
2008年 | 84篇 |
2007年 | 62篇 |
2006年 | 71篇 |
2005年 | 53篇 |
2004年 | 68篇 |
2003年 | 65篇 |
2002年 | 56篇 |
2001年 | 42篇 |
2000年 | 49篇 |
1999年 | 32篇 |
1998年 | 24篇 |
1997年 | 30篇 |
1996年 | 24篇 |
1995年 | 24篇 |
1994年 | 15篇 |
1993年 | 14篇 |
1992年 | 39篇 |
1991年 | 23篇 |
1990年 | 38篇 |
1989年 | 46篇 |
1988年 | 29篇 |
1987年 | 26篇 |
1986年 | 27篇 |
1985年 | 36篇 |
1984年 | 23篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 16篇 |
1979年 | 10篇 |
1978年 | 11篇 |
1977年 | 18篇 |
1975年 | 11篇 |
1971年 | 9篇 |
1969年 | 8篇 |
1967年 | 9篇 |
排序方式: 共有2072条查询结果,搜索用时 15 毫秒
1.
2.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
3.
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients 总被引:5,自引:0,他引:5
H T Robertson N R Haley M Guthrie D Cardenas J W Eschbach J W Adamson 《American journal of kidney diseases》1990,15(4):325-332
The objective of this study was to quantitate the improvement in exercise capacity produced in anemic chronic hemodialysis (HD) patients after correction of their anemia with recombinant human erythropoietin (rHuEPO). The maximal exercise capacity and quadriceps strength of 19 anemic HD patients was tested before and after correction of the anemia with rHuEPO. A progressive work exercise protocol (PWET) on a cycle ergometer was used to compare measurements of maximal oxygen uptake (VO2max), maximal heart rate, and subjective assessment of fatigue during the test. Measurements of quadriceps strength were performed before the cycle ergometer studies. At baseline, all patients had reduced VO2max (15.3 +/- 5.4 mL/kg/min) and maximal exercise heart rates (138.5 +/- 23.9 beats/min). rHuEPO increased the mean hematocrit from 21.2% to 35%, and this was associated with a 17% increase (P less than 0.0005) in the VO2max. At any specified work load, rHuEPO treatment decreased heart rate, minute ventilation, and the subjective perception of fatigue. Both isometric and isokinetic measurements of quadriceps strength were improved following administration of rHuEPO. The maximal exercise heart rate was decreased in comparison to the baseline measurements (P less than 0.04), suggesting that in contrast to normal subjects, HD patients stop exercise before oxygen transport limitations are reached. In this unselected group of chronic HD patients, rHuEPO produced clinically significant improvements in both aerobic exercise capacity and isometric and isokinetic quadriceps strength. The improvement in aerobic capacity was substantially less than would have been expected from the correction of a comparable degree of anemia in non-HD patients. None of the 19 treated patients attained the exercise performance level predicted for a sedentary normal subject. 相似文献
4.
5.
A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. 总被引:3,自引:0,他引:3
The erythropoietic response to graded doses of recombinant human erythropoietin (epoetin alfa) was assessed in 24 hemodialysis patients by quantitative ferrokinetic studies, and measurement of the reticulocyte count and plasma levels of transferrin receptor protein. These responses were compared to those of 22 normal subjects. Epoetin alfa was given intravenously at 15, 50 or 150 U/kg every other day for four injections. Three patients with chronic renal failure were restudied after renal function was restored following renal transplantation. The results of these three different measurements of erythroid function showed that the acute response to recombinant human erythropoietin was similar in normal subjects and patients with renal failure. We conclude that chronic uremia does not alter the responsiveness to erythropoietin in vivo. 相似文献
6.
7.
Normal and diseased isolated lungs: high-resolution CT 总被引:8,自引:0,他引:8
8.
9.
Verbal Working Memory and Atherosclerosis in Patients with Cardiovascular Disease: An fMRI study 总被引:1,自引:0,他引:1
Andreana P. Haley PhD Lawrence H. Sweet PhD John Gunstad PhD Daniel E. Forman MD Athena Poppas MD Robert H. Paul PhD David F. Tate PhD Ronald A. Cohen PhD 《Journal of neuroimaging》2007,17(3):227-233
BACKGROUND AND PURPOSE: Intimal-medial thickening (IMT) of the carotid wall is an accepted peripheral marker of atherosclerosis. It is associated with increased risk for myocardial infarction and stroke, and lower attention-executive-psychomotor functioning. The purpose of this study was to examine the relationship between IMT and brain activity during a verbal working memory (VWM) task in patients with cardiovascular disease (CVD). METHODS: Thirteen CVD patients underwent functional magnetic resonance imaging (fMRI) during a 2-Back VWM task, and B-mode ultrasound of the carotid arteries. IMT was calculated using an automated algorithm based on a validated edge-detection technique. The relationship between IMT and 2-Back-related brain activity was modeled using partial correlations controlling for age and small vessel disease as measured by white matter signal hyperintensities on MRI (WMH). RESULTS: Higher IMT was associated with lower 2-Back-related signal intensity and in the right middle frontal gyrus, independent of age and WMH. CONCLUSIONS: IMT may be one mechanism contributing to brain dysfunction in CVD. The blood oxygenation level-dependent (BOLD) contrast appears to be highly sensitive to peripheral vascular health as measured by IMT. Future studies should examine the sensitivity and specificity of the BOLD response for predicting cognitive decline in CVD. 相似文献
10.